Concepedia

Michael G. Schlieman

MG

6

Publications

564

Citations

6

H-Index

2003

Active since

Affiliations

University of California Davis Medical Center(Current)

University of California, Davis

Michael G. Schlieman is an author at University of California Davis Medical Center specializing in medicine, oncology, and cancer research.

Top concepts

Publications per year

2003–2007

6

Publications

6

Utility of Tumor Markers in Determining Resectability of Pancreatic Cancer

Michael G. Schlieman · Archives of Surgery · 2003 · 172 citations

Targeting BCL-2 overexpression in various human malignancies through NF-κB inhibition by the proteasome inhibitor bortezomib

Bridget N. Fahy, Michael G. Schlieman, Melinda M. Mortenson et al. · Cancer Chemotherapy and Pharmacology · 2005 · 125 citations

, , +10

Inhibition of AKT abrogates chemotherapy- induced NF-κB survival mechanisms: implications for therapy in pancreatic cancer1

Bridget N. Fahy, Michael G. Schlieman, Subbulakshmi Virudachalam et al. · Journal of the American College of Surgeons · 2004 · 99 citations

Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancer

Bridget N. Fahy, Michael G. Schlieman, S. Virudachalam et al. · Journal of Surgical Research · 2003 · 59 citations

, , +7

Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer

Melinda M. Mortenson, Michael G. Schlieman, Subbulakshmi Virudachalam et al. · Lung Cancer · 2005 · 55 citations

, , +9

Rows per page

1–5 of 6